BDBM302096 US9598415, 12

SMILES CCS(=O)(=O)c1ccc(CNc2nc3cnc(nc3n([C@@H](C)C(C)C)c2=O)-c2c(OC)ncnc2C2CC2)nc1

InChI Key InChIKey=GYCNFUZSEJLGGX-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 302096   

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM302096(US9598415, 12)
Affinity DataIC50: 300nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM302096(US9598415, 12)
Affinity DataIC50: 310nMAssay Description:Antagonist activity at GAL4 DBD-fused human RORgamma LBD expressed in pGL4.3 luc2P/GAL4UAS/hygro and pBIND transfected HEK293 cells assessed as inhib...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM302096(US9598415, 12)
Affinity DataIC50: 13nMAssay Description:Antagonist activity at RORgamma in human PBMC assessed as reduction in anti-CD3/IL-23 stimulated IL-17 level measured after 3 days by MSD assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2022
Entry Details Article
PubMed